Announcements

June C. Lemerand, VP and Chief Information Officer of Snap-on Inc, filed a Form 4 on August 11, 2026, reporting the exercise of two stock option grants and the sale of 4,352 shares of common stock on the same date.

Richard Scott Struthers, President and CEO of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), filed a Form 4 on August 11, 2026, reporting four stock option exercises executed on August 7, 2026.

A Form 4 filed on August 11, 2026, with the U.S. Securities and Exchange Commission reports that L. William Krause, a director of Vistance Networks, Inc. (NASDAQ:VISN), disposed of 102,300 shares of common stock on August 10, 2026, via a gift transaction at a …

A Form 4 filed on August 11, 2026, disclosed that James Poppens, a Vice President at Interface Inc (NASDAQ:TILE), sold 10,000 shares of common stock on August 11, 2026, at a weighted average price of $38.43 per share.

Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Tomas Kiselak, and Peter Harwin filed a joint Form 4 on August 11, 2026, reporting stock option exercises in Apogee Therapeutics, Inc. (NASDAQ:APGE) dated August 7, 2026.

Robert Pridgen, Chief Accounting Officer of Interface Inc, filed a Form 4 on August 11, 2026, disclosing the sale of 8,000 shares of Interface Inc common stock on that same date.

Apogee Therapeutics, Inc. filed a Form 8-K on August 11, 2026, disclosing the results of a special stockholder meeting held the same day, at which shareholders voted to adopt the merger agreement with a subsidiary of AbbVie Inc., and reporting the anticipated resignations of …